Key facts
- This page summarizes Leonard E. Post's Form 4 filing for CG Oncology, Inc. (CGON).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Dec 2024, 18:51.
Leonard E. Post - 06 Dec 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)
- Reporting relationship
- Director
- Issuer ticker
- CGON
- Reported as of
- 06 Dec 2024
- Net transaction value
- -$33,942
- SEC form
- 4
- Accepted by SEC
- 06 Dec 2024, 18:51:46 UTC
- Prior SEC filing
- 07 Oct 2024
- Next SEC filing
- 17 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua F. Patterson, Attorney-in-Fact for Leonard Post
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Leonard E. Post filed Form 4 for CG Oncology, Inc. (CGON) on 06 Dec 2024.
Change
- Previous filing in this sequence was filed on 07 Oct 2024.
- Current net transaction value: -$33,942.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CGON
transaction
Common Stock
Options Exercise
- Transaction value
- $600
- Shares
- +1,000
- Change %
- Price
- $0.6000
- Shares after
- 1,000
- Date
- 06 Dec 2024
- Ownership
- Direct
CGON
transaction
Common Stock
Sale
- Transaction value
- $25,798
- Shares
- -750
- Change %
- -75%
- Price
- $34.40
- Shares after
- 250
- Date
- 06 Dec 2024
- Ownership
- Direct
- Footnotes
- F1, F2
CGON
transaction
Common Stock
Sale
- Transaction value
- $8,744
- Shares
- -250
- Change %
- -100%
- Price
- $34.98
- Shares after
- 0
- Date
- 06 Dec 2024
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CGON
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -1,000
- Change %
- -0.74%
- Price
- $0.000000
- Shares after
- 134,077
- Date
- 06 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000
- Exercise price
- $0.6000
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024.
Footnote F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $33.91 to $34.87. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Footnote F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $34.92 to $35.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Footnote F4
Fully vested.